Ravi Mehrotra's Stock Ratings

UBS Analyst

Ravi Mehrotra is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/06/2025

Overall Average Return

-1.01%

Smart Score

36.1%

Overall Average Return Percentile

37th

Number of Ratings

3
Buy NowGet Alert
11/13/2024IRBuy Now
Ingersoll Rand
$69.7077.91%
Ravi Mehrotra36%
$102 → $124AssumesBuy → BuyGet Alert
02/03/2020CRSPBuy Now
CRISPR Therapeutics
$32.9757.72%
Ravi Mehrotra36%
$85 → $52DowngradeOutperform → In-LineGet Alert
04/12/2019CRSPBuy Now
CRISPR Therapeutics
$32.97
Ravi Mehrotra36%
Initiates → OutperformGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free